Plain-English translation of NCT06259513 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether breast cancer surgery can be personalized based on each patient's tumor type and how many lymph nodes are affected. For some patients with early-stage, slower-growing breast cancers, researchers want to know if they can skip certain lymph node surgery or have a simpler procedure instead of more extensive surgery. The goal is to reduce surgical side effects while keeping cancer outcomes just as good.
Currently, many breast cancer patients have extensive lymph node surgery (called axillary clearance) even when their cancer is unlikely to have spread to many nodes. This larger surgery takes more time, costs more, and can cause lasting side effects like arm swelling and numbness. This trial exists to see if personalized surgery—based on tumor type and actual lymph node involvement—can be just as effective while reducing these complications.
You likely qualify if…
You likely don't qualify if…
You will have breast surgery as planned, and depending on which study group you join, you may either skip lymph node sampling entirely or have a simpler lymph node biopsy instead of full lymph node removal. The research team will track your recovery, check for any surgical side effects, and follow up with you over time to monitor for cancer recurrence and your overall health. Participation involves regular follow-up visits and appointments to evaluate how well you're doing.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Singapore